How it may work
A diet-derived sulfur compound transported by OCTN1. Higher measured blood or plasma exposure does not establish target-tissue delivery, clinical benefit, disease prevention or finished-product bioavailability.
Lifespan / validated healthspanEvidence level E
Level E marks a central question without dependable direct human evidence; read the outcome conclusion rather than treating the letter as a direction of effect.
This E grade answers the central longevity question only. Other outcomes are graded separately below.Why people are interested
A food-derived compound transported into cells by OCTN1. Exact preparations can raise measured blood exposure, but the largest cognition trial was primary-null and no human trial shows longer lifespan or validated healthspan.
Outcome map
One ingredient. Different questions.
Evidence can be stronger for a specific marker or population and weaker for a broader promise. Each row answers a separate question.
- 01Evidence level E
Human lifespan or validated healthspan
No completed human intervention reviewed demonstrated longer lifespan, validated healthspan, age reversal, disease prevention or treatment.
- 02Evidence level B
Circulating exposure
Exact named oral preparations raised measured circulating exposure under tested conditions; this does not establish clinical efficacy or cross-source equivalence.
- 03Evidence level C
Objective cognition
The human landscape is mixed and the largest completed trial was primary-null, so a reliable broad cognitive benefit has not been established.
- 04Evidence level C
Subjective and objective sleep
Null global or intention-to-treat results coexist with isolated subscale, factor or exploratory EEG signals and do not establish a broad sleep benefit.
- 05Evidence level E
Purified-material skin benefit
No adequate purified-material trial was identified, and whole-mushroom findings cannot be attributed to L-ergothioneine alone.
- 06Evidence level B
Short-term tolerability
Selected adults showed no consistent serious product-attributed pattern under exact observed conditions; broader or long-term safety is not established.
Library trackResearch Radar
Last reviewed22 Aug 2026
Guide scopeIngredient research only
What people have studied
Exact tested oral preparations increase measured circulating exposure, but exposure is not efficacy. The largest completed cognition trial was primary-null; positive cognition, sleep, skin and biomarker signals are exploratory, formulation-specific or limited by analysis-set, multiplicity, matrix and sponsor concerns. No completed human intervention demonstrates longer lifespan or validated healthspan.
What to consider
Selected short trials did not show a consistent serious product-attributed pattern under their exact conditions. They do not establish long-term, rare-event, interaction or vulnerable-population safety, and findings do not transfer across purified, fermented, mixed-extract, mushroom or finished-product sources.
Local pathway
This science review does not establish a Thailand market route. Ingredient source, process, specification and finished-product status require separate official confirmation.
Sources + indexes
See where the explanation comes from.
Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.